Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

China Leads India on Drug Patents and Academic Drug Research

publication date: Jul 14, 2011
China’s academic and research institutions received 15% of all patents granted worldwide for drug research in 2007-2008. That far outpaced the 2% that India’s institutions were awarded, and it also handily topped the 5% garnered by US academics. In terms of scientific papers, Indian researchers are third in the world, having published 4,642 biopharma papers in the last decade. However, during the same time period, China published 5,720, good for second place, and the US took first place with 13,314. (Data compiled by the Boston Consulting Group.) More details....

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital